Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can health literacy shield rheumatic disease patients from online health anxiety?

NCT ID NCT06993935

Knowledge-focused Sponsor: Gulseren Demir Karakilic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers compare health literacy, rational drug use, and cyberchondria among people with inflammatory rheumatic diseases, knee osteoarthritis, and healthy adults. The study enrolls 228 participants across three groups and asks them to complete surveys about health knowledge, medication habits, and online health anxiety. The goal is to understand how these factors relate to each other and to disease activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study identifies links between health literacy, medication habits, and online health anxiety, it could inform patient education programs for people with rheumatic diseases.
What could go wrong
This is a small observational study that cannot prove cause and effect. The findings may not apply to other patient groups or healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

228 people

The number who actually took part.

Started

Jan 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 18 to 65 years, including patients diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or knee osteoarthritis, as well as healthy controls matched for age and gender. All participants had sufficient cognitive abilities, were literate, and consented to participate.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Obtained approval from the local ethics committee. Provided informed consent to participate. Aged 18 to 65 years. Possessed intact cognitive functions. Literate. For the Rheumatoid Arthritis (RA) group: Met the 2010 ACR criteria for Rheumatoid Arthritis. For the Ankylosing Spondylitis (AS) group: Met the Modified New York criteria. For the Psoriatic Arthritis (PsA) group: Met the Classification of Psoriatic Arthritis (CASPAR) criteria. For the Knee Osteoarthritis (KOA) control group: Visited the Physical Medicine and Rehabilitation clinic due to knee pain lasting six months or longer. Diagnosed with knee osteoarthritis. Matched the patient group in terms of age and gender. Demonstrated adequate cognitive abilities. Possessed literacy skills. For the Healthy control group: Same age and gender as the patient group. Had good cognitive functions. Literate. Had no disease or complaints. Exclusion Criteria: Under the age of 18 or over the age of 65. Any condition that could impair communication. Refusal to participate in the study. Not possessing digital devices such as a smartphone or computer, or lacking internet access. Illiterate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis arthritic joint disease Chronic Disease osteoarthritis, knee psoriatic arthritis rheumatic disorder rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease Cyberchondria Health literacy Inflammatory arthritis Rational drug use Rheumatoid arthritis

Contacts and locations

Locations

  • Yozgat Bozok University

    Yozgat, Yozgat, 66100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.